Część 7

This tender, designated as "Część 7," is being issued by a contracting authority in Poland and pertains to the procurement of pharmaceutical supplies. Specifically, the tender seeks the supply of 240 packages of Bexarotenum. This represents a direct procurement of a specific medicinal product, likely for use within the Polish healthcare system or by a designated public health institution.

The contracting authority is looking to establish a reliable supply chain for this medication, ensuring its availability for patients. Typical requirements for such pharmaceutical tenders often include adherence to strict quality standards, such as Good Manufacturing Practice (GMP) and relevant European Medicines Agency (EMA) or national regulatory body approvals. Bidders will likely be expected to demonstrate their capacity to deliver the specified quantity within agreed-upon timelines and under specified storage and transportation conditions. Furthermore, documentation regarding the product's origin, batch traceability, expiry dates, and any necessary import permits will be crucial. The tender process will likely involve a detailed evaluation of technical specifications, economic offers, and the supplier's ability to meet all regulatory and quality assurance requirements for pharmaceutical products within the European Union. Interested parties should prepare to submit comprehensive proposals addressing all aspects of supply, quality control, and logistical support for Bexarotenum.